
Oppenheimer Asset Management Inc. has acquired a new stake of 479,674 shares in CVS Health Corporation, valued at approximately $49.62 million, during the second quarter. This investment comes as institutional investors collectively own 80.66% of CVS's outstanding stock, and the company has shown strong financial performance with quarterly EPS of $2.58 and revenue of $106.10 billion. Analysts maintain a positive outlook for CVS, with a consensus price target of $106.75, and the company also offers a quarterly dividend of $0.665 per share.
MarketBeat
Original source
cvs health digital
Check live status on DownRightNow

